1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: March 22-28, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: March 22-28, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 03/24/2026
Location: Washington, DC
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator Bill Cassidy (R-LA)

Event Date: 03/24/2026
Location: Washington, DC
Subject: Promote Innovation in Cell and Gene Therapy, and Rare Disease Treatments
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Bobby Gaspar, Christina Hartman, Frank Thomas (Orchard Therapeutics);

Event Date: 03/24/2026
Location: Washington, DC
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator Roger Marshall (R-KS)

Event Date: 03/25/2026
Location: Washington, DC
Subject: American Health Insurance Plans (AHIP) 2026 Medicare, Medicaid, Duals, and Commercial Markets Forum; Speaker: Fireside Chat
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, advocacy groups, and other stakeholders

Event Date: 03/25/2026
Location: Washington, DC
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representative Andy Harris (R-MD)

Event Date: 03/26/2026
Location: Silver Spring, MD
Subject: Innovation in the Rare Disease Ecosystem
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Curran Simpson (Regenxbio);

Event Date: 03/26/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representative Richard Hudson (R-NC)

Event Date: 03/26/2026
Location: Silver Spring, MD
Subject: GLP-1 Drugs and Compounding
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Caitlin Koury (Checkmate Government Relations); Chad Yelinski, Chris Pernie, Michael Doustdar (Novo Nordisk);

Event Date: 03/27/2026
Location: Washington, DC
Subject: Global Healthcare Innovation Workshop Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Jess Jones, Matthew Duong, Michelle Liu (World Economic Forum);

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs

No Significant Event

Official Name: Sean R. Keveney, Chief Counsel

Event Date: 03/24/2026
Location: Washington, DC
Subject: Vaping Issues 
FDA Participant/Group: N/A
Non FDA Participant/Group: Brad Humphreys, Derek Lyons (Kings Legal); Mike Rubino (Foward Global); Tony Abboud (Vapor Technology Association);

Event Date: 03/26/2026
Location: Virtual
Subject: Organ Procurement and Transplantation Network (OPTN) Regulatory Changes
FDA Participant/Group: KATHERINE SZARAMA; GRACE GRAHAM; ROSA SHERAFAT-KAZEMZADEH; 
Non FDA Participant/Group: Camillo Ricordi, Shelley Ross (The Cure Alliance);

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods

Event Date: 03/23/2026
Location: Atlanta, GA
Subject: Association of Food and Drug Officials (AFDO) Healthy People 2030 Food Safety Initiative Meeting; Speaker: Fireside Chat - Healthy People Initiative
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Foods industry, trade associations, academia, and government

Event Date: 03/25/2026
Location: Washington, DC
Subject: Human Foods Program Priorities
FDA Participant/Group: LAURA PILLSBURY; BRIAN FAHEY; MAHLET GOITOM; 
Non FDA Participant/Group: Senate Health, Education, Labor and Pensions Committee representatives

Event Date: 03/26/2026
Location: Washington, DC
Subject: Introductory Meeting
FDA Participant/Group: REBECCA BUCKNER; 
Non FDA Participant/Group: Dan Magliocco, Nancy Dowling, Pat Maloney, Stephanie Goodwin (Danone); Ken Barbic (Invariant LLC);

Event Date: 03/27/2026
Location: College Park, MD
Subject: Dietary Supplement Innovation and the Scope of Dietary Ingredients Public Meeting; Speaker: Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, dietary supplement industry, academia, trade associations, and consumers

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 03/24/2026
Location: Miami, FL
Subject: Personal Care Product Council’s (PCPC) 2026 Beauty Collective Summit; Speaker: FDA Update - Current Priorities and Key Developments
FDA Participant/Group: LUKE HALL; 
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 03/26/2026
Location: Washington, DC
Subject: Enhancing Early-Stage Drug Development Roundtable
FDA Participant/Group: BENJAMIN COOK; KARIM MIKHAIL; 
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

Event Date: 03/26/2026
Location: Silver Spring, MD
Subject: SIRCE II Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Thomas Christl (Softtek Government Solutions);

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 03/24/2026
Location: Virtual 
Subject: Annual Foundations in Discovery, Drugs and Diagnostics Conference; Speaker: Keynote 
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, academia, and other stakeholders

Event Date: 03/25/2026
Location: Virtual
Subject: Alliance for a Stronger FDA Webinar; Speaker: CDRH Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Patient group members, consumer advocates, and industry representatives

Event Date: 03/26/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates 
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Boston Scientific representatives

Event Date: 03/26/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: GE HealthCare representatives

Event Date: 03/27/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Johnson and Johnson representatives

Official Name: Tracy Beth Høeg M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine

No Significant Event

Back to Top